1
Understanding the Cosmetic Products Regulation 1223/2009 and REACH
Dr. Annelie Struessmann, Technical Director, CONUSBAT
London, 15. October 2013
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 2
Agenda
● EU Sector Industry Legislation
● Key Elements of REACH and the CPR
● Interfaces for the Regulatory Frameworks
● Testing Requirements from REACH
● The Animal Testing Ban
● Conclusions - Q & A
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 3
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 4
The internal market is the core of today’s European
Union and as a consequence people, goods, services
and money move around as freely as they do within
one country.
The Single or Internal Market
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 5
1. Automotives 2. Chemicals 3. Construction products 4. Cosmetics 5. Return of cultural goods 6. Defense related products 7. Electrical equipment 8. Equipment intended for use in
Potentially Explosive Atmospheres (ATEX)
9. Footwear 10.Gas Appliances
11.Medical devices 12.Mechanical equipment
(machinery, lifts) 13.Metrology and pre-packaging 14.Pharmaceuticals 15.Pressure equipment 16.Radio and telecommunications
terminal equipment (R&TTE) 17.Rail 18.Textiles 19.Toys 20.Weapons and many others
The Single Market for Goods – Regulated Industry Sectors
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 6
*http://europa.eu/documentation/legislation/pdf/oa8107147_en.pdf
THE ABC OF EUROPEAN UNION LAW*
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 7
is a regulation of the European Union, adopted to improve the protection of human health and the environment from the risks that can be posed by chemicals, while enhancing the competitiveness of the EU chemicals industry. It also promotes alternative methods for the hazard assessment of substances in order to reduce the number of tests on animals.
REACH
REACH > > > > Registration, Evaluation,
Authorization and Restriction of Chemicals
> Pre-market approval
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 8
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 9
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 10
Dr. A. Struessmann, 15. October 2013
Cosmetic Products Regulation (CPR)
The Cosmetics Regulation requires that every cosmetic product placed on the market in Europe is safe to use. The manufacturer must ensure that cosmetic products undergo an expert scientific safety assessment before they are launched for sale.
> In-market Surveillance
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 11
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 12
REACH - Preamble 13
This Regulation should apply without prejudice to the prohibitions and restrictions laid down in Council Directive 76/768/EEC* of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products in so far as substances are used and marketed as cosmetic ingredients and are within the scope of this Regulation. A phase-out of testing on vertebrate animals for the purpose of protecting human health as specified in Directive 76/768/EEC* should take place with regard to the uses of those substances in cosmetics.
Dr. A. Struessmann, 15. October 2013
*[Regulation (EC) Nr. 1223/2009]
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 13
REACH - Preamble 13
This Regulation should apply without prejudice to the prohibitions and restrictions laid down in Council Directive 76/768/EEC* of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products in so far as substances are used and marketed as cosmetic ingredients and are within the scope of this Regulation. A phase-out of testing on vertebrate animals for the purpose of protecting human health as specified in Directive 76/768/EEC* should take place with regard to the uses of those substances in cosmetics.
Dr. A. Struessmann, 15. October 2013
*[Regulation (EC) Nr. 1223/2009]
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 14
Dr. A. Struessmann, 15. October 2013
SUMMARY:
Regulation (EC) Nr. 1223/200 is the decisive framework for Cosmetic Products The Cosmetics Product Regulation contains legal provisions for the product ingredients (ingredient lists in the CPR‘s annexes), for product labelling and on animal testing. Also, the identification and labeling of hazardous substances is regulated in the CPR.
● REACH APPLIES TO COSMETIC INGREDIENTS, BUT NOT TO COSMETIC PRODUCTS
● COSMETIC PRODUCTS -MIXTURES IN THE FINISHED STATE, INTENDED FOR THE FINAL USER- ARE EXEMPT FROM ALL PROVISIONS OF CLP
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 15
> pre-market approval
Test Requirements for Registration > 1 t/a
Annex VII > 10 t/a
Annex VIII > 100 t/a Annex IX
> 1000 t/a Annex X
Price Euro
Acute oral X X X X 1.500
Acute dermal X / O X/O X/O 2.000
Acute inhalative X /O X/O X/O 11.700
Skin irritation X X X X 1.500
Eye irritation X X X X 1.500
Sensitization X X X X 4.200
Ames assay X X X X 3.200
Chromosome aberration O X X X 19.200
Additional mutagenicity studies O X X X 17.300
Reprotox Screening X 54.600
Teratogenicity X X 63.100
28 day test X O 49.400
90 day test X X 115.000
Chronic study O 300.000
2 generation study O O 328.000
Carcinogenicity study O 780.000
REACH
Source: Regulatory Workshop InCosmetics 2011 – M.Kleber
>
O: Involves an expert decision
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 16
Cosmetic Products Regulation (CPR)
Manufacturer Responsibility for
Product Safety
Cosmetic Product Safety
Assessment
> In-market Surveillance
*SCCS - Notes of Guidance for the Testing of Cosmetic Substances and their Safety Evaluation, 8th Revision http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_s_006.pdf
Dr. A. Struessmann, 15. October 2013
1 Acute toxicity ................................................................................ 2 Corrosivity and irritation ............................................................... 3 Skin sensitization ........................................................................... 4 Dermal / percutaneous absorption .............................................. 5 Repeated dose toxicity .................................................................. 6 Reproductive toxicity ..................................................................... 7 Mutagenicity / genotoxicity............................................................ 8 Carcinogenicity .............................................................................. 9 Toxicokinetic studies ...................................................................... 10 Photo-induced toxicity ................................................................. 11 Human data ..................................................................................
RELEVANT TOXICITY STUDIES ON COSMETIC SUBSTANCES*
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 17
Comparison of Test Requirements
REACH CPR
Acute oral Acute toxicity
Acute dermal " Acute inhalative '
Skin irritation Corrosivity and irritation
Eye irritation "
Sensitization Skin sensitization
Ames assay Mutagenicity/genotoxicity
Chromosome aberration '
Additional mutagenicity studies '
Reprotox Screening Reproductive toxicity
Teratogenicity '
28 day test Repeated dose toxicity
90 day test '
Chronic study '
2 generation study ' Carcinogenicity study Carcinogenicity
Dermal / percutaneous absorption
Toxicokinetic studies
Photo-induced toxicity
Human data
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 18
Dr. A. Struessmann, 15. October 2013
Ban on Animal Testing
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 19
Dr. A. Struessmann, 15. October 2013
Ban on Animal Testing
IMPLEMENTATION DEADLINES
• Testing ban on finished cosmetic products 11 Sept. 2004
• Testing ban on ingredients or combination of ingredients 11 March 2009
• Marketing ban when tested for human health effects with 11 March 2009 the exception of the specific effects of repeated-dose toxicity, reproductive toxicity and toxicokinetics
• Marketing ban when tested on the specific effects 11 March 2013
The ban applies irrespectively on the availability of alternative non-animal tests
Dr. A. Struessmann, 15. October 2013
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 20
REACH - Information Requirements, Test Methods and Quality of Data
Article 13(3) of the REACH Regulation requires that new tests need to be performed acc. to the test guidelines in Regulation (EC) No. 440/2008* or in accordance with other international test methods recognized by the European Commission or ECHA.
*http://eur-lex.europa.eu/JOHtml.do?uri=OJ:L:2008:142:SOM:EN:HTML
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 21
Dr. A. Struessmann, 15. October 2013
Status on Validation of In-Vitro Alternatives to Animal Testing
Acute systemic toxicity Recommendations
Skin irritation / corrosion Validated in vitro test methods
Eye irritation Validated in vitro test methods
+ peer reviews
Sensitization Peer reviews
Mutagenicity/genotoxicity Validated in vitro test methods
Reproductive toxicity Peer reviews and foreseen validations &
accepted methods
Repeated dose toxicity -
Carcinogenicity study Recommendations and drafts
Dermal / percutaneous absorption Validated in vitro test methods
Toxicokinetic studies Peer review
Photo-induced toxicity Validated in vitro test methods EU COMMISSION COMMUNICATION on the animal testing and marketing ban – March 2013: http://ec.europa.eu/consumers/sectors/cosmetics/files/pdf/animal_testing/com_at_2013_en.pdf
Tracking System for Alternative test methods: http://tsar.jrc.ec.europa.eu/index.php?endpoint=6&method=6
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 22
Dr. A. Struessmann, 15. October 2013
Other Alternatives to Animal Testing - in-silico, in-chemico methods
ADVERSE OUTCOME PATHWAYS
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 23
Dr. A. Struessmann, 15. October 2013
CONCLUSIONS
The future of safety assessment for cosmetic ingredients and other chemicals is a multi-tier approach of using in-vitro, in-silico and in-chemico methods. Actually, many elements are available, however, some are still under exploration.
Multi-tier approaches will assure compliance with REACH and the CPR.
The animal testing ban does not apply to chemicals with application in other areas than cosmetics - therefore, no break in seeking REACH compliance exists. This includes chemicals used as cosmetic ingredients when multiple applications exist.
For many new cosmetic ingredients the existing alternatives already allow for a comprehensive safety assessment according to Annex I/CPR - read-across and tests on humans are examples for data sources in weight-of-evidence approaches which can be used in addition to alternative testing.
As REACH applies only from a threshold of 1 tonne/year, cosmetics assessed in a WoE approach can be introduced into the EU internal market.
Delays in innovation due to the animal testing ban will appear in only minor dimensions.
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 24
Dr. A. Struessmann, 15. October 2013
Ban on Animal Testing
Costs? - Facts ● An increased demand for experts and science
sector specialists is required.
● The number of tests and costs per test will be reduced.
● An issue is the availability of experts.
● When comparing costs for a multi-tier alternative approach to a set of animal tests priorly used they appear to be in similar dimension.
Understanding the Cosmetic Products Regulation 1223/2009 and REACH 25
Dr. Annelie Struessmann Kruppstr. 18 D-52072 Aachen, Germany
Tel: +49241 51857790
Skype: annelie.struessmann
www.conusbat.com